Renaissance Technologies’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$850K	Buy	276,800 +251,378	+989%	+$1.09M	﹤0.01%	2349
2025 Q4	$90.5K	Buy	+25,422	New	+$156K	﹤0.01%	3022
2025 Q2	–	Sell	-14,000	Closed	-$120K	–	3548
2025 Q1	$120K	Sell	14,000 -199,200	-93%	-$1.88M	﹤0.01%	3164
2024 Q4	$2.29M	Sell	213,200 -30,600	-13%	-$235K	﹤0.01%	1972
2024 Q3	$1.38M	Sell	243,800 -222,637	-48%	-$1.28M	﹤0.01%	2249
2024 Q2	$1.97M	Buy	466,437 +386,537	+484%	+$1.56M	﹤0.01%	1896
2024 Q1	$407K	Buy	+79,900	New	+$450K	﹤0.01%	2954
2022 Q4	–	Sell	-367,100	Closed	-$3.79M	–	4109
2022 Q3	$3.79M	Buy	367,100 +9,300	+3%	+$98.1K	0.01%	1609
2022 Q2	$3.58M	Buy	+357,800	New	+$3.39M	﹤0.01%	1790
2021 Q1	–	Sell	-63,100	Closed	-$341K	–	3300
2020 Q4	$341K	Buy	+63,100	New	+$333K	﹤0.01%	2988
2020 Q2	–	Sell	-407,400	Closed	-$1.28M	–	3426
2020 Q1	$1.28M	Buy	407,400 +325,859	+400%	+$1.14M	﹤0.01%	2303
2019 Q4	$211K	Buy	+81,541	New	+$214K	﹤0.01%	3184
2019 Q1	–	Sell	-18,109	Closed	-$28K	–	3437
2018 Q4	$28K	Buy	+18,109	New	+$41.1K	﹤0.01%	3312